Literature DB >> 32010350

ASSOCIATION OF IRS1 GLY971ARG GENE POLYMORPHISM WITH INSULIN RESISTANCE IN IRANIAN NEWLY DIAGNOSED DIABETIC ADULTS.

H Shakeri1, A Khoshi2,3, M Kaffash Bajestani4, A Farahi5, M S Javadzadeh6, Z Hosseini2, R Mohammadi7.   

Abstract

CONTEXT: Insulin receptor substrate-1 (IRS-1) has an important role in insulin signaling and the common Gly971Arg polymorphism is related to type 2 diabetes (T2D). IRS-1 Gly971Arg polymorphism can modify tyrosine phosphorylation at a specific site of IRS-1 and may have a critical role in the development of insulin resistance (IR).
OBJECTIVE: The purpose of this study was to investigate the association between this polymorphism and IR in Iranian patients with newly-diagnosed type 2 diabetes.
DESIGN: The study was conducted on 114 individuals with newly-diagnosed T2D and 118 healthy matched controls, aged 20-80 years. Fasting blood glucose and insulin were measured by the enzymatic method and enzyme-linked immunosorbent assay, respectively. Insulin-resistance was calculated by homeostasis model assessment estimated-insulin resistance (HOMA-IR). The gene polymorphism was examined by polymerase chain reaction-restriction fragment length polymorphism.
RESULTS: There are significant differences between IRS1 Gly971Arg polymorphism and studied individuals (P<0.0001). The findings showed that the risk of developing T2D in individuals who had R-alleles was 3.74 folds higher than those without R-alleles. However, IRS1 Gly971Arg polymorphism was not associated with high HOMA-IR, high BMI and familial history of diabetes.
CONCLUSIONS: Even though there was not a significant relationship between IRS-1 G971R polymorphism with insulin resistance and high BMI, this polymorphism was correlated to newly-diagnosed diabetic patients. Thus, the evaluation of IRS-1 G971R polymorphism may be helpful for predicting T2D new cases. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  IRS-1; gene polymorphism; insulin resistance; type 2 diabetes

Year:  2019        PMID: 32010350      PMCID: PMC6992408          DOI: 10.4183/aeb.2019.317

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  40 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.

Authors:  I Hirayama; H Tamemoto; H Yokota; S K Kubo; J Wang; H Kuwano; Y Nagamachi; T Takeuchi; T Izumi
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

3.  Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study.

Authors:  H H Lei; J Coresh; A R Shuldiner; E Boerwinkle; F L Brancati
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

4.  Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism.

Authors:  Piero Marchetti; Roberto Lupi; Massimo Federici; Lorella Marselli; Matilde Masini; Ugo Boggi; Silvia Del Guerra; Giovanni Patanè; Salvatore Piro; Marcello Anello; Ettore Bergamini; Francesco Purrello; Renato Lauro; Franco Mosca; Giorgio Sesti; Stefano Del Prato
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

5.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus.

Authors:  Y Imai; A Fusco; Y Suzuki; M A Lesniak; R D'Alfonso; G Sesti; A Bertoli; R Lauro; D Accili; S I Taylor
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

7.  Amino acid polymorphisms of the insulin receptor substrate-1 in Japanese noninsulin-dependent diabetes mellitus.

Authors:  H Mori; M Hashiramoto; M Kishimoto; M Kasuga
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

8.  Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.

Authors:  J O Clausen; T Hansen; C Bjørbaek; S M Echwald; S A Urhammer; S Rasmussen; C B Andersen; L Hansen; K Almind; K Winther
Journal:  Lancet       Date:  1995-08-12       Impact factor: 79.321

Review 9.  Defects of the insulin receptor substrate (IRS) system in human metabolic disorders.

Authors:  G Sesti; M Federici; M L Hribal; D Lauro; P Sbraccia; R Lauro
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

10.  Association of Omentin rs2274907 and FTO rs9939609 gene polymorphisms with insulin resistance in Iranian individuals with newly diagnosed type 2 diabetes.

Authors:  Amirhosein Khoshi; Mehdi Kaffash Bajestani; Habibesadat Shakeri; Golnaz Goodarzi; Fatemeh Azizi
Journal:  Lipids Health Dis       Date:  2019-06-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.